MedTrace Logo

Study of Treatment Choice in Patients With Localized Prostate Cancer

NCT01177865 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Gathering information about patients with prostate cancer may help doctors learn more about how patients choose treatment options.

PURPOSE: This study is looking at treatment choice in patients with localized prostate cancer.

Conditions

Interventions

OTHER

informational intervention

OTHER

questionnaire administration

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Mark Emberton, MD, FRCS, MBBS · University College London Hospitals

Study Design

Purpose
HEALTH_SERVICES_RESEARCH

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01177865 on ClinicalTrials.gov